Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2011
04/20/2011CN102026998A Spirocyclic derivatives as histone deacetylase inhibitors
04/20/2011CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof
04/20/2011CN102026990A Novel inhibitors of hepatitis c virus replication
04/20/2011CN102026983A Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
04/20/2011CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
04/20/2011CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
04/20/2011CN102026637A Lipoprotein lipase-activating compositions comprising benzene derivates
04/20/2011CN102020646A Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
04/20/2011CN101525335B Full-bridge linked triphenylamine compound and application thereof in electroluminescent device
04/20/2011CN101348483B Preparation of phenanthroindolizidine derivative
04/20/2011CN101314595B Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof
04/20/2011CN101200466B Heterocyclic compounds having antithrombotic activity, preparation method and uses thereof
04/19/2011US7928237 Fused ring azadecalin glucocorticoid receptor modulators
04/19/2011US7928224 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same
04/19/2011US7928133 Compounds and compositions as hedgehog signaling pathway modulators
04/19/2011US7928131 Imidazole compounds
04/19/2011US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists
04/19/2011US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
04/19/2011US7927830 Modified carbocyanine dyes and their conjugates
04/19/2011US7927623 Pleasant taste; bioabsorbable; overcoated water insoluble drug in alcohol solvent and water soluble binder; mixing, compression
04/19/2011CA2539476C Quinazoline potassium channel inhibitors
04/19/2011CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/19/2011CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents
04/16/2011CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044535A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/14/2011WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044197A1 Spirocyclic compounds as modulators of chemokine receptor activity
04/14/2011WO2011043491A1 Novel artificial fluorescent bases
04/14/2011WO2011043359A1 Pharmaceutical product containing aromatic heterocyclic compound
04/14/2011WO2011042798A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
04/14/2011WO2011042560A1 Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
04/14/2011WO2011042474A1 Novel estrogen receptor ligands
04/14/2011WO2011042389A2 Phenylpyri(mi)dinylazoles
04/14/2011WO2011042107A2 Materials for organic electroluminescent devices
04/14/2011WO2011015936A3 An improved process for the preparation of pure paliperidone
04/14/2011US20110087028 Method for preparing clopidogrel and its derivatives
04/14/2011US20110087024 process for the preparation of paliperidone intermediates
04/14/2011US20110086834 Alkynyl alcohols as kinase inhibitors
04/14/2011US20110086818 Methods, compositions, and kits for treating pain and pruritus
04/14/2011US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
04/14/2011US20110086112 Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
04/14/2011US20110086088 Compositions and methods for treatment of mammalian skin
04/14/2011US20110086086 Transdermal system for varenicline
04/14/2011DE102009048791A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
04/14/2011CA2784277A1 Pyrazoles derivatives modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
04/14/2011CA2777209A1 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
04/14/2011CA2776884A1 Materials for organic electroluminescent devices
04/14/2011CA2776770A1 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/14/2011CA2776690A1 Heterocyclic compounds useful as pdk1 inhibitors
04/14/2011CA2773205A1 Phenylpyri(mi)dinylazoles
04/13/2011EP2308879A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
04/13/2011EP2308877A1 Imidazopyridin-2-on derivative
04/13/2011EP2308870A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
04/13/2011EP2308867A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
04/13/2011EP2308866A1 Phenylpyri(mi)dinylpyrazoles and their use as fungicides
04/13/2011EP2308851A1 Imidazolone and imidazolidinone derivatives as 11B-HSD1 inhibitors for the treatment of diabetes
04/13/2011EP2308846A2 Caspase inhibitors and uses thereof
04/13/2011EP2308845A2 Caspase inhibitors and uses thereof
04/13/2011EP2308844A2 Caspase inhibitors and uses thereof
04/13/2011EP2308843A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound
04/13/2011EP2308833A2 Cyclic protein tyrosine kinase inhibitors
04/13/2011EP2308562A2 Azetidine ring compounds and drugs comprising the same
04/13/2011EP2307413A1 Novel phenyl-imidazopyridines and pyridazines
04/13/2011EP2307412A2 Heterocyclic derivatives as modulators of ion channels
04/13/2011EP2307411A1 Triazolopyridine compounds useful as kinase inhibitors
04/13/2011EP2307410A1 Aza-beta-carbolines and methods of using same
04/13/2011EP2307409A1 Pyrrolopyridines as kinase inhibitors
04/13/2011EP2307402A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
04/13/2011EP2307401A2 Antineoplastic derivatives of 4-oxo-1,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof
04/13/2011EP2307400A2 Inhibitors of pi3 kinase
04/13/2011EP2307378A1 Nicotinamide derivatives
04/13/2011EP2307008A1 Substituted indolyl and indazolyl derivatives and uses thereof
04/13/2011EP2158201B1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
04/13/2011EP1745046B1 1 h-indazoles, benzothiazoles, 1,2-benziosoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
04/13/2011CN102015711A Spiro-indole derivatives for the treatment of parasitic diseases
04/13/2011CN102015710A Azatricyclic antibiotic compounds
04/13/2011CN102015709A Heterocyclic antiviral compounds
04/13/2011CN102015708A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
04/13/2011CN102015707A RAF inhibitor compounds and methods of use thereof
04/13/2011CN102015706A Imidazolidinone derivatives as 11B-HSD1 inhibitors
04/13/2011CN102015705A Fused heterocyclic derivative and use thereof
04/13/2011CN102015704A Pyrimidinyl pyridone inhibitors of JNK
04/13/2011CN102015703A Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device
04/13/2011CN102015702A Cyclic ethers
04/13/2011CN102015700A Antibacterial condensed thiazoles
04/13/2011CN102015691A Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors
04/13/2011CN102015686A Novel heterocyclic compounds and uses therof
04/13/2011CN102015680A New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
04/13/2011CN102015651A Compounds and compositions as TLR activity modulators
04/13/2011CN102015645A Piperidine and pyrrolidine compounds
04/13/2011CN102015641A Heterocyclic compound
04/13/2011CN102015640A Substituted 4-aminocyclohexane derivatives for the treatment of pain
04/13/2011CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists
04/13/2011CN102014902A Inhibitors of checkpoint kinases
04/13/2011CN102010416A Substituted tetrahydroquinolines
04/13/2011CN102010413A Organic electro-luminescent compound and luminescent device using same
04/13/2011CN102010412A Organic electroluminescent compound and luminescent device using same
04/13/2011CN102010411A Organic electroluminescent compound and luminescent device using same
04/13/2011CN102010410A Heterocyclic compound and organic light emitting device including same